Cleared Traditional

K982592 - DOCKING-EXTENSION WIRE

K982592 is an FDA 510(k) clearance for DOCKING-EXTENSION WIRE, manufactured by Schneider (Europe) GmbH. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 89-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1998
Decision
89d
Days
Class 2
Risk

K982592 is an FDA 510(k) clearance for the DOCKING-EXTENSION WIRE. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Schneider (Europe) GmbH (Bulach, SE). The FDA issued a Cleared decision on October 21, 1998 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Schneider (Europe) GmbH devices

FDA 510(k) Submission Details - K982592

510(k) Number K982592 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 24, 1998
Decision Date October 21, 1998
Days to Decision 89 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 125d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 522
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K982592.
STRATEGY CORONARY WIRE GUIDE
K983771 · Cook, Inc. · Nov 1998
HI-TORQUE STEELCORE 18 GUIDE WIRE MODEL NUMBERS 1003280, 1003281, 1003282
K982876 · Guidant Corp. · Nov 1998
ACS HT BALANCE MIDDLEWEIGHT GUIDE WIRE
K983033 · Guidant Corp. · Nov 1998
BARD HYDROPHILLIC COATED GUIDE WIRE
K974713 · C.R. Bard, Inc. · Oct 1998
ACS HI-TORQUE BALANCE HEAVYWEIGHT GUIDE WIRE WITH HYDROCOAT HYDROPHILIC COATING
K982083 · Guidant Corp. · Sep 1998
CORE AND COIL ASSEMBLY GUIDEWIRE
K971322 · Lake Region Mfg., Inc. · Jul 1998